Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ball, GB

Anthony John Ball, Newcastle GB

Patent application numberDescriptionPublished
20090280558Process For Dynamic Kinetic Resolution (DKR) Of Racemic Compounds In (Hydro) Fluorocarbon Solvents - A process for preparing a third compound stereo-selectively which process comprises reacting a substrate comprising a first enantiomeric compound with a racemisation catalyst to give a second enantiomeric compound, and concurrently reacting the second enantiomeric compound in the presence of a biological catalyst to give the third compound, wherein the process is performed in a solvent comprising at least one (hydro) fluorocarbon. The biological catalyst is preferably an enzyme. The substrate preferably comprises a racemate of the first and second enantiomeric compounds. The second enantiomeric compound may be reacted with a reagent, such as acyl donor, to form the third compound in the presence of the biological catalyst.11-12-2009

Billie Ball, Middlesex GB

Patent application numberDescriptionPublished
20110217429CENTREFILLED CONFECTIONERY COMPOSITION - A confectionery composition is provided which comprises a chocolate shell and a continuous filling. The chocolate shell comprises convoluted chocolate sheet. Also provided is a confectionery composition comprising a tubular shell defining a tubular cavity therein, and a filling located in the cavity. Again, the shell comprises a convoluted chocolate sheet. Methods of making confectionery compositions comprising a convoluted chocolate sheet and a filling are also described.09-08-2011

Daniel G. Ball, Winchester GB

Patent application numberDescriptionPublished
20120110147USING WIRELESS TECHNOLOGY TO DIRECT COMPLEX WIRING CONFIGURATIONS - An apparatus, method and computer program for managing a computer network, the network comprising at least one network device and a plurality of unconnected network ports, the apparatus comprising: a send component for sending an identification message to each network device; a receive component, responsive to the send component sending the identification message, for receiving at least one identification response from the network; an analyze component, responsive to the receive component receiving an identification response, for determining the plurality of unconnected network ports comprising a first network port; an identify component, responsive to the analyze component determining the plurality of unconnected network ports, for determining the first network port; and a send component, responsive to the identify component determining the first network port, operable for sending a first location message to the first network port.05-03-2012

Graham Ball, Nottingham GB

Patent application numberDescriptionPublished
20110282819DATA ANALYSIS METHOD AND SYSTEM - The present invention relates to the analysis of data to identify relationships between the input data and one or more conditions. One method of analysing such data is by the use of neural networks which are non-linear statistical data modelling tools, the structure of which may be changed based on information that is passed through the network during a training phase. A known problem that affects neural networks is the issue of overtraining which arises in overcomplex or overspecified systems when the capacity of the network significantly exceeds the needed parameters. The present invention provides a method of analysing data using a neural network with a constrained architecture that mitigates the problems associated with the prior art.11-17-2011

James M. Ball, Suffolk GB

Patent application numberDescriptionPublished
20090279023LIQUID CRYSTAL CELL AND A DISPLAY - A liquid crystal cell (11-12-2009

Jonathan Ball, Dundee GB

Patent application numberDescriptionPublished
20120095945 METHOD OF CREATING A COMPUTER MODEL OF THE PHYSICAL WORLD - A method of executing a computer application in the context of a computer model comprising the steps of retrieving computer model data from a model server, retrieving application information from an application server, and executing said application information in the context of the model in an execution environment.04-19-2012

Jonathan Ball, Nottingham GB

Patent application numberDescriptionPublished
20090110685Treatment and prevention of viral infections - Disclosed is polynucleotide encoding a polypeptide comprising an antibody binding site, the polypeptide being able to bind to HCV E2 samples representative of each of HCV genotypes 1-6, as well as polypeptides having such properties and uses of such polypeptides in detecting and treating HCV infection.04-30-2009

Jonathan K. Ball, Newark GB

Patent application numberDescriptionPublished
20100104555HCV neutralizing epitopes - The invention relates to modified hepatitis C virus E2 polypeptides that are effective in eliciting the production of cross-neutralizing antibodies against hepatitis C virus. The invention provides modified hepatitis C virus E2 polypeptides, preparations and pharmaceutical compositions containing them, as well as methods for using these modified E2 polypeptides.04-29-2010

Kathryn Lindsay Ball, Dundee GB

Patent application numberDescriptionPublished
20080249025Methods and Means For Inhibition of CDK4 Activity10-09-2008

Lawrence Ball, London GB

Patent application numberDescriptionPublished
20090254206System and method for composing individualized music - A system, apparatus, and method for generating audio information based upon information corresponding to a user. The system including one or more controllers which input user information, form one or more streams of information based upon the user information, create a pattern in accordance with the user information, and generate audio information based upon the pattern. Further, the one or more controllers can optionally communicate with each other using wired or wireless (e.g., a cellular) networking systems.10-08-2009

Leslie Derek Ball, Dundee GB

Patent application numberDescriptionPublished
20100302000BIOMETRIC IDENTIFY VERIFICATION INCLUDING STRESS STATE EVALUATION - Subject matter disclosed herein may relate to a biometric security technique, and may relate to biometric identity verification and emotional stress state evaluation.12-02-2010

Martin Ball, High Wycombe GB

Patent application numberDescriptionPublished
20090097068DEVICE AUTHORIZATION SYSTEM USING OPTICAL SCANNER - A method and apparatus for controlling access to a device having a scanner that is used for scanning images into memory and a plurality of features. The method comprises optically scanning a tag with the scanner, receiving information from the tag during the scanning process, and determining whether a bearer of the tag can access the device at all based upon information scanned from the tag.04-16-2009

Patent applications by Martin Ball, High Wycombe GB

Matthew Ball, Macclesfield GB

Patent application numberDescriptionPublished
20110112144METHODS OF PREPARING SUBSTITUTED HETEROCYCLES - The present disclosure relates to methods of preparing substituted thiophenes, which are useful for the treatment and prevention of cancers. Also disclosed are substituted thiophenes made by the methods disclosed herein.05-12-2011

Matthew David Ball, Newcastle-Under-Lyme GB

Patent application numberDescriptionPublished
20090058471Rail-to-rail comparator with hysteresis - A comparator, comprising at least one current stage for providing a first current proportional to a difference between first and second comparator inputs, the first current being provided to an amplifier input; an amplifier for amplifying a current provided to the amplifier input and providing a comparator output; apparatus for introducing hysteresis, comprising at least one of a current source and a current sink, the current source being arranged to selectively source a source current to the amplifier input such that the comparator output changes from a first state to a second state when a difference between the first and second inputs rises above a first value, and the current sink being arranged to selectively sink a sink current from the amplifier input such that the comparator output changes from the second state to the first state when the difference between the first and second inputs falls below a second value; and apparatus for controlling at least one of the source current and the sink current to be proportional to a bias current of the current stage.03-05-2009

Neris Ball, Belfast GB

Patent application numberDescriptionPublished
20090092634Chicken Virus Vaccine and Diagnostic - A novel astrovirus designated chicken astrovirus type 3 has been isolated and characterised. Nucleotide sequences and polypeptide sequences of this astrovirus are provided with uses of the same and the isolated astrovirus in assay kits and vaccines.04-09-2009

Sarah Ball, Oxfordshire GB

Patent application numberDescriptionPublished
20120046161TERNARY PLATINUM ALLOY CATALYST - A platinum alloy catalyst PtXY, wherein X is nickel, cobalt, chromium, copper, titanium or manganese and Y is tantalum or niobium, characterised in that in the alloy the atomic percentage of platinum is 46-75 at %, of X is 1-49 at % and of Y is 1-35 at %; provided that the alloy is not 66 at % Pt20 at % Cr14 at % Ta or 50 at % Pt, 25 at % Co, 25 at % Ta is disclosed. The catalyst has particular use as an oxygen reduction catalyst in fuel cells, and in particular in phosphoric acid fuel cells.02-23-2012

Simon Ball, Birmingham GB

Patent application numberDescriptionPublished
20100215619HLA PEPTIDE THERAPY - The invention provides polypeptides derived from a major histocompatibility complex (MHC) class I human leukocyte antigen (HLA), such as HLA-A2, and derivatives or analogues thereof. The polypeptides, derivatives and analogues can be used to treat or prevent allosensitisation, such as the treatment or prevention of allograft rejection.08-26-2010
20110038881PROGNOSTIC ASSAY FOR DETERMINING T CELL RESPONSE TO HLA ANTIGENS AND USE THEREOF IN FIELD OF TISSUE TRANSPLANTATION - The invention provides an in vitro method of determining whether an individual is at risk of, or undergoing, graft damage or rejection of immune origin and/or damage of immune origin to non-graft tissue using polypeptides derived from a major histocompatibility complex (MHC) class I human leukocyte antigen (HLA), such as HLA-A2, and derivatives or analogues thereof.02-17-2011